OPKO Health ROE 2010-2024 | OPK
Current and historical return on equity (ROE) values for OPKO Health (OPK) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| OPKO Health ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-06-30 | $-0.24B | $1.40B | -17.66% |
| 2024-03-31 | $-0.25B | $1.25B | -17.93% |
| 2023-12-31 | $-0.19B | $1.39B | -12.70% |
| 2023-09-30 | $-0.21B | $1.45B | -13.59% |
| 2023-06-30 | $-0.21B | $1.54B | -13.32% |
| 2023-03-31 | $-0.29B | $1.55B | -18.01% |
| 2022-12-31 | $-0.33B | $1.56B | -20.11% |
| 2022-09-30 | $-0.32B | $1.63B | -19.07% |
| 2022-06-30 | $-0.20B | $1.72B | -11.91% |
| 2022-03-31 | $-0.12B | $1.62B | -6.81% |
| 2021-12-31 | $-0.03B | $1.69B | -1.74% |
| 2021-09-30 | $0.08B | $1.77B | 4.42% |
| 2021-06-30 | $0.07B | $1.74B | 4.22% |
| 2021-03-31 | $0.12B | $1.70B | 7.35% |
| 2020-12-31 | $0.03B | $1.67B | 1.93% |
| 2020-09-30 | $-0.11B | $1.62B | -7.09% |
| 2020-06-30 | $-0.20B | $1.59B | -12.45% |
| 2020-03-31 | $-0.29B | $1.55B | -17.99% |
| 2019-12-31 | $-0.32B | $1.62B | -18.72% |
| 2019-09-30 | $-0.28B | $1.64B | -16.16% |
| 2019-06-30 | $-0.25B | $1.71B | -13.90% |
| 2019-03-31 | $-0.19B | $1.76B | -10.68% |
| 2018-12-31 | $-0.15B | $1.79B | -8.48% |
| 2018-09-30 | $-0.30B | $1.79B | -16.24% |
| 2018-06-30 | $-0.30B | $1.81B | -16.02% |
| 2018-03-31 | $-0.31B | $1.82B | -15.97% |
| 2017-12-31 | $-0.31B | $1.84B | -15.02% |
| 2017-09-30 | $-0.13B | $2.09B | -5.96% |
| 2017-06-30 | $-0.10B | $2.11B | -4.95% |
| 2017-03-31 | $-0.07B | $2.11B | -3.41% |
| 2016-12-31 | $-0.05B | $2.09B | -2.34% |
| 2016-09-30 | $-0.01B | $2.11B | -0.44% |
| 2016-06-30 | $0.13B | $2.02B | 6.73% |
| 2016-03-31 | $0.08B | $2.00B | 4.43% |
| 2015-12-31 | $-0.03B | $1.98B | -2.15% |
| 2015-09-30 | $-0.09B | $1.97B | -7.65% |
| 2015-06-30 | $-0.26B | $0.83B | -31.16% |
| 2015-03-31 | $-0.24B | $0.81B | -28.30% |
| 2014-12-31 | $-0.17B | $0.84B | -19.84% |
| 2014-09-30 | $-0.14B | $0.89B | -15.53% |
| 2014-06-30 | $-0.15B | $0.91B | -16.87% |
| 2014-03-31 | $-0.13B | $0.83B | -17.34% |
| 2013-12-31 | $-0.12B | $0.87B | -19.38% |
| 2013-09-30 | $-0.10B | $0.87B | -23.59% |
| 2013-06-30 | $-0.05B | $0.31B | -20.48% |
| 2013-03-31 | $-0.06B | $0.32B | -28.61% |
| 2012-12-31 | $-0.03B | $0.18B | -19.62% |
| 2012-09-30 | $-0.01B | $0.15B | -7.82% |
| 2012-06-30 | $-0.01B | $0.15B | -7.72% |
| 2012-03-31 | $-0.01B | $0.16B | -4.54% |
| 2011-12-31 | $-0.00B | $0.16B | -2.41% |
| 2011-09-30 | $-0.02B | $0.10B | -24.44% |
| 2011-06-30 | $-0.02B | $0.11B | -30.22% |
| 2011-03-31 | $-0.02B | $0.12B | -40.55% |
| 2010-12-31 | $-0.02B | $0.02B | -56.38% |
| 2010-09-30 | $-0.03B | $0.02B | -75.95% |
| 2010-06-30 | $-0.03B | $0.05B | -63.37% |
| 2010-03-31 | $-0.03B | $0.06B | -64.92% |
| 2009-12-31 | $-0.04B | $0.03B | -110.24% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.011B | $0.864B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $212.628B | 25.94 |
| Intuitive Surgical (ISRG) | United States | $186.738B | 97.63 |
| Alcon (ALC) | Switzerland | $45.674B | 32.15 |
| IQVIA Holdings (IQV) | United States | $39.509B | 21.77 |
| Edwards Lifesciences (EW) | United States | $38.832B | 24.66 |
| IDEXX Laboratories (IDXX) | United States | $35.456B | 41.76 |
| DexCom (DXCM) | United States | $26.916B | 40.53 |
| Waters (WAT) | United States | $22.926B | 33.90 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.977B | 0.00 |
| STERIS (STE) | Ireland | $21.252B | 24.49 |
| Hologic (HOLX) | United States | $18.417B | 19.43 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.517B | 12.85 |
| Sysmex ADR (SSMXY) | Japan | $12.405B | 38.90 |
| Globus Medical (GMED) | United States | $11.099B | 28.27 |
| Teleflex (TFX) | United States | $9.197B | 14.67 |
| Penumbra (PEN) | United States | $8.945B | 87.62 |
| Masimo (MASI) | United States | $8.639B | 41.80 |
| Glaukos (GKOS) | United States | $7.682B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.022B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.514B | 25.59 |
| Inari Medical (NARI) | United States | $3.035B | 0.00 |
| TransMedics (TMDX) | United States | $2.870B | 90.96 |
| Veracyte (VCYT) | United States | $2.868B | 86.84 |
| LivaNova (LIVN) | United Kingdom | $2.823B | 16.30 |
| Nihon Kohden (NHNKY) | Japan | $2.488B | 18.90 |
| Elekta AB (EKTAY) | Sweden | $2.336B | 19.03 |
| Tandem Diabetes Care (TNDM) | United States | $2.188B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.968B | 10.29 |
| RxSight (RXST) | United States | $1.881B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.334B | 0.00 |
| Artivion (AORT) | United States | $1.214B | 80.50 |
| Pulse Biosciences (PLSE) | United States | $1.106B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.939B | 15.96 |
| IRadimed (IRMD) | United States | $0.707B | 38.23 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.696B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.668B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.666B | 0.00 |
| SiBone (SIBN) | United States | $0.649B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.638B | 15.10 |
| Paragon 28 (FNA) | United States | $0.591B | 0.00 |
| AxoGen (AXGN) | United States | $0.582B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.492B | 0.00 |
| CVRx (CVRX) | United States | $0.377B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.370B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.366B | 19.81 |
| Delcath Systems (DCTH) | United States | $0.304B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.291B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.276B | 18.50 |
| Sight Sciences (SGHT) | United States | $0.235B | 0.00 |
| Inogen (INGN) | United States | $0.224B | 0.00 |
| NeuroPace (NPCE) | United States | $0.221B | 0.00 |
| Accuray (ARAY) | United States | $0.210B | 0.00 |
| Nevro (NVRO) | United States | $0.199B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.189B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.156B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.129B | 0.00 |
| 908 Devices (MASS) | United States | $0.126B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.114B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.107B | 15.95 |
| EDAP TMS S.A (EDAP) | France | $0.101B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.090B | 0.00 |
| LENSAR (LNSR) | United States | $0.080B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.079B | 0.00 |
| Hyperfine (HYPR) | United States | $0.070B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.068B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| InspireMD (NSPR) | Israel | $0.059B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.054B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.053B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.047B | 0.00 |
| Envoy Medical (COCH) | United States | $0.040B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| Neuronetics (STIM) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.029B | 0.00 |
| Precision Optics (POCI) | United States | $0.029B | 0.00 |
| Spectral AI (MDAI) | United States | $0.025B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.020B | 0.00 | |
| Ekso Bionics Holdings (EKSO) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.014B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |